Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 59126 - 59150 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Piroxicam	Approved Investigational	ATP6V1D	51382	downregulated	Piroxicam results in decreased expression of ATP6V1D mRNA	14q23.3	A23661
Piroxicam	Approved Investigational	AURKA	6790	downregulated	Piroxicam results in decreased expression of AURKA mRNA	20q13.2	A23661
Piroxicam	Approved Investigational	BAG5	9529	downregulated	Piroxicam results in decreased expression of BAG5 mRNA	14q32.33	A23661
Piroxicam	Approved Investigational	BARD1	580	downregulated	Piroxicam results in decreased expression of BARD1 mRNA	2q35	A23661
Piroxicam	Approved Investigational	BAZ1A	11177	downregulated	Piroxicam results in decreased expression of BAZ1A mRNA	14q13.1-q13.2	A23661
Piroxicam	Approved Investigational	BCAR3	8412	downregulated	Piroxicam results in decreased expression of BCAR3 mRNA	1p22.1	A23661
Piroxicam	Approved Investigational	BCCIP	56647	downregulated	Piroxicam results in decreased expression of BCCIP mRNA	10q26.2	A23661
Piroxicam	Approved Investigational	BCL2A1	597	downregulated	Piroxicam results in decreased expression of BCL2A1 mRNA	15q25.1	A21015
Piroxicam	Approved Investigational	BIRC5	332	upregulated	Piroxicam results in increased expression of BIRC5 mRNA	17q25.3	A23661
Piroxicam	Approved Investigational	BMP2K	55589	upregulated	Piroxicam results in increased expression of BMP2K mRNA	4q21.21	A23661
Piroxicam	Approved Investigational	BRCC3	79184	downregulated	Piroxicam results in decreased expression of BRCC3 mRNA	Xq28	A23661
Piroxicam	Approved Investigational	BST2	684	downregulated	Piroxicam results in decreased expression of BST2 mRNA	19p13.11	A21015
Piroxicam	Approved Investigational	BTG1	694	downregulated	Piroxicam results in decreased expression of BTG1 mRNA	12q21.33	A23661
Piroxicam	Approved Investigational	BUB1B	701	downregulated	Piroxicam results in decreased expression of BUB1B mRNA	15q15.1	A23661
Piroxicam	Approved Investigational	CACYBP	27101	downregulated	Piroxicam results in decreased expression of CACYBP mRNA	1q25.1	A23661
Piroxicam	Approved Investigational	CADM1	23705	downregulated	Piroxicam results in decreased expression of CADM1 mRNA	11q23.3	A23661
Piroxicam	Approved Investigational	CALM1	801	downregulated	Piroxicam results in decreased expression of CALM1 mRNA	14q32.11	A23661
Piroxicam	Approved Investigational	CAND1	55832	upregulated	Piroxicam results in increased expression of CAND1 mRNA	12q14.3-q15	A23661
Piroxicam	Approved Investigational	CAPG	822	downregulated	Piroxicam results in decreased expression of CAPG mRNA	2p11.2	A23661
Piroxicam	Approved Investigational	CAPN7	23473	downregulated	Piroxicam results in decreased expression of CAPN7 mRNA	3p25.1	A23661
Piroxicam	Approved Investigational	CAPZA2	830	downregulated	Piroxicam results in decreased expression of CAPZA2 mRNA	7q31.2	A23661
Piroxicam	Approved Investigational	CAST	831	upregulated	Piroxicam results in increased expression of CAST mRNA	5q15	A23661
Piroxicam	Approved Investigational	CAV1	857	downregulated	Piroxicam results in decreased expression of CAV1 mRNA	7q31.2	A23661
Piroxicam	Approved Investigational	CCDC85B	11007	upregulated	Piroxicam results in increased expression of CCDC85B mRNA	11q13.1	A23661
Piroxicam	Approved Investigational	CCL20	6364	downregulated	Piroxicam results in decreased expression of CCL20 mRNA	2q36.3	A21015

Displaying entries 59126 - 59150 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability